Gestione dell’ansia, stress post-traumatico e dei disordini ossessivo-compulsivi/feed/ISRCTN48075063

Search Results

ACC/AHA: linee guida per la gestione delle cardiopatie congenite negli adulti

Cardiovascolare

Cardiovascolare

L’ACC e l’AHA, in collaborazione con diverse importanti società mediche, hanno pubblicato una nuova linea guida clinica incentrata...
Read More Read More: ACC/AHA: linee guida per la gestione delle cardiopatie congenite negli adulti

Gestione della malattia arteriosa periferica negli adulti con diabete: linea guida

Cardiovascolare

Cardiovascolare

L’American College of Cardiology (ACC)  ha pubblicato un nuovo documento scientifico che fornisce raccomandazioni basate su...
Read More Read More: Gestione della malattia arteriosa periferica negli adulti con diabete: linea guida

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

Circulation, Ahead of Print. BACKGROUND:We report IMPROVE-DiCE (Improve Diabetic Cardiac Energetics), a 2-part open-label, phase 2a trial evaluating the safety and effectiveness of ninerafaxstat, a novel therapeutic designed to enhance cardiac energetics. Between May and September 2021, part 1 enro…
Read More Read More: IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes Data di pubblicazione: Dicembre 2025

Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothelial Toxicity and Cardiac Dysfunction

Circulation, Ahead of Print. BACKGROUND:Doxorubicin (DOX), an effective chemotherapeutic drug for various cancers, has been demonstrated to induce cardiovascular toxicity in cancer survivors. Endothelial cell (EC) dysfunction is recognized to play a critical role in the onset and severity of cardio…
Read More Read More: Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothelial Toxicity and Cardiac Dysfunction Data di pubblicazione: Dicembre 2025

Standard di cura per il Diabete – 2026

Endocrinologia e Malattie Metaboliche

Endocrinologia e Malattie Metaboliche

L’American Diabetes Association (ADA) ha pubblicato gli “Standards of Care in Diabetes—2026“, linee guida basate su evidenze...
Read More Read More: Standard di cura per il Diabete – 2026

ESC 2025: Linee guida sulla gestione delle miocarditi e pericarditi

Cardiovascolare

Cardiovascolare

L’European Society of Cardiology ha aggiornato nel 2025 le linee guida dedicate alla gestione della miocardite e della pericardite,...
Read More Read More: ESC 2025: Linee guida sulla gestione delle miocarditi e pericarditi

[Articles] Artifical intelligence-powered delta-NIHSS-based model for predicting recurrence, disability and mortality after acute ischaemic strokes (DISCO): a modelling study

The DISCO model, incorporating 23 clinical variables, demonstrates high accuracy, robustness, clinical accessibility, and explainability in predicting post-stroke outcomes. The predictive strength of delta-NIHSS(admission-discharge) provides mechanistic insights into stroke outcomes and could poten…
Read More Read More: [Articles] Artifical intelligence-powered delta-NIHSS-based model for predicting recurrence, disability and mortality after acute ischaemic strokes (DISCO): a modelling study Data di pubblicazione: Dicembre 2025

[Articles] Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment

Our qualitative findings suggests that psilocybin treatment, when administered with standardised preparation and treatment support, may offer a meaningful therapeutic opportunity for Patients with PTSD. Future work should include larger controlled studies and use mixed methods to explore how sympto…
Read More Read More: [Articles] Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment Data di pubblicazione: Dicembre 2025

Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling

The intricate interplay between the gut microbiota and the GI tract has garnered significant attention, as growing evidence has identified the inflammasome as a crucial yet underexplored master regulator in microbiota-driven diseases. Triggered by a variety of dangers, inflammasomes are supramolecu…
Read More Read More: Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling Data di pubblicazione: Dicembre 2025

Reassessing the prophylactic effect of clip closure to prevent delayed rebleeding after colorectal endoscopic submucosal dissection

We read with great interest the recent EPOC trial by Miyakawa et al, published in Gut, investigating the efficacy of prophylactic clip closure following colorectal endoscopic submucosal dissection (ESD). The authors deserve recognition and appreciation for conducting a well-designed, multicentre ra…
Read More Read More: Reassessing the prophylactic effect of clip closure to prevent delayed rebleeding after colorectal endoscopic submucosal dissection Data di pubblicazione: Dicembre 2025

Prevenzione, diagnosi e gestione della BPCO (GOLD 2026)

BPCO

BPCO

Presentato l’aggiornamento 2026 delle linee guida del Global Initiative for Chronic Obstructive Lung Disease (GOLD) durante la...
Read More Read More: Prevenzione, diagnosi e gestione della BPCO (GOLD 2026)

Adesione ai trattamenti ASA + Statine in medicina generale: evidenze da uno studio italiano real-world

Notizie dalla Ricerca

Notizie dalla Ricerca

Questo studio real-world basato mostra un punto molto chiaro: i pazienti che assumono ASA e statina come due farmaci separati hanno livelli...
Read More Read More: Adesione ai trattamenti ASA + Statine in medicina generale: evidenze da uno studio italiano real-world
Close Search Window
Close